Can Real-Time feedback rewire walking in diabetic nerve damage?

NCT ID NCT05965336

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 09, 2026 · Last updated Aug 19, 2026 · Updated 5 times

Summary

This study compares walking patterns between people with diabetic peripheral neuropathy (nerve damage from diabetes) and healthy adults. It also tests whether giving people real-time feedback on their walking form can immediately change how they walk. The goal is to understand the biomechanical differences and explore whether feedback-based training could improve mobility and reduce foot injury risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this research could point toward simple, feedback-based walking training to improve mobility and reduce foot injury risk in people with diabetic nerve damage.
What could go wrong
This is an early, small observational and feasibility study (50 participants). It is not designed to prove a treatment works, and any benefits seen may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Dec 2024

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

45 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria for All Participants: 1. Age 45+ years 2. Able to walk 10-meters independently without an assistive device 3. Sufficient cardiovascular and musculoskeletal health to walk on a treadmill for 1-minute at self-selected speed Inclusion Criteria for Participants with DPN: 1. Diagnosis of DM 2. Diagnosis of DPN by a physician 3. Foot examination within the past 6 months to document ambulatory status 4. Physician's clearance Exclusion Criteria for Healthy Able-Bodied Individuals: 1. History of neurologic disease 2. History of orthopaedic disease affecting the lower extremities 3. History of injury or pain affecting the lower extremity or walking function within the past 6 months Exclusion Criteria for All Participants: 1. History of amputation 2. Active ulceration 3. Medial column deformity 4. History of Charcot osteoarthropathy 5. History of posterior muscle group lengthening 6. History of lower extremity joint replacement 7. History of lower extremity and/or foot surgery affecting walking mechanics 8. Orthopaedic problems of the lower limbs or spine due to other medical conditions (not DM or DPN) that limit walking or cause pain during walking 9. Improper footwear for walking and community ambulation 10. Cardiovascular or medical condition affecting ability to walk safely 11. History of unexplained dizziness or fainting in the past 2 months 12. Allergy to adhesive tape or rubbing alcohol 13. Individuals who are pregnant, prisoners, or not yet adults 14. Inability to communicate with the investigators 15. Inability to provide written informed consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Diabetic peripheral neuropathy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Florida Institute for Human and Machine Cognition

    RECRUITING

    Pensacola, Florida, 32502, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.